JP2025513753A5 - - Google Patents

Info

Publication number
JP2025513753A5
JP2025513753A5 JP2024557969A JP2024557969A JP2025513753A5 JP 2025513753 A5 JP2025513753 A5 JP 2025513753A5 JP 2024557969 A JP2024557969 A JP 2024557969A JP 2024557969 A JP2024557969 A JP 2024557969A JP 2025513753 A5 JP2025513753 A5 JP 2025513753A5
Authority
JP
Japan
Prior art keywords
cov
sars
polynucleotide
natural
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024557969A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025513753A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/058069 external-priority patent/WO2023186946A1/en
Publication of JP2025513753A publication Critical patent/JP2025513753A/ja
Publication of JP2025513753A5 publication Critical patent/JP2025513753A5/ja
Pending legal-status Critical Current

Links

JP2024557969A 2022-03-28 2023-03-28 ワントゥーストップ(one-to-stop)弱毒化SARS-CoV-2ウイルス Pending JP2025513753A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP22164874.4 2022-03-28
EP22164874 2022-03-28
EP22201198.3 2022-10-12
EP22201198 2022-10-12
PCT/EP2023/058069 WO2023186946A1 (en) 2022-03-28 2023-03-28 One-to-stop attenuated sars-cov-2 virus

Publications (2)

Publication Number Publication Date
JP2025513753A JP2025513753A (ja) 2025-04-30
JP2025513753A5 true JP2025513753A5 (https=) 2026-04-08

Family

ID=92636797

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024557969A Pending JP2025513753A (ja) 2022-03-28 2023-03-28 ワントゥーストップ(one-to-stop)弱毒化SARS-CoV-2ウイルス

Country Status (9)

Country Link
US (1) US20250295757A1 (https=)
EP (1) EP4499141A1 (https=)
JP (1) JP2025513753A (https=)
KR (1) KR20240163164A (https=)
CN (1) CN119136829A (https=)
AU (1) AU2023244474A1 (https=)
CA (1) CA3244307A1 (https=)
IL (1) IL315075A (https=)
MX (1) MX2024011903A (https=)

Similar Documents

Publication Publication Date Title
JP2023512519A5 (https=)
JP7846986B2 (ja) 生物学的製剤の投与のためのアルファウイルスベースのレプリコン
JP2023519640A5 (https=)
KR100996330B1 (ko) Hiv 조절/부속 단백질의 융합 단백질
TWI828168B (zh) 用作b型肝炎病毒(hbv)疫苗之自我複製rna分子及其用途
JP2014527404A5 (https=)
JP2013501038A5 (https=)
JP5740473B2 (ja) ヒトパピローマウイルス変形体及び免疫増強剤を含む子宮頸癌の予防または治療用組成物
RU2012107671A (ru) Композиция для лечения инфекции вирусом гепатита в
WO2003059381A2 (en) Immunogenic preparations and vaccines on the basis of mrna
JP2022505877A5 (https=)
US10435712B2 (en) Evolution of high-titer virus-like vesicles for vaccine applications
JP2002542827A5 (https=)
JP2005511019A5 (https=)
JP2004501646A5 (https=)
Wiener et al. Evolution of reovirus genes: a comparison of serotype 1, 2, and 3 M2 genome segments, which encode the major structural capsid protein μ1C
JP2023522154A5 (https=)
KR20110044971A (ko) 신규 융합 단백질과 상기 단백질의 c형 간염 백신으로의 사용
JP2025513753A5 (https=)
JP7163547B2 (ja) 新規ペプチドおよびその用途
CN107073078B (zh) 利用肝细胞生长因子和基质细胞衍生因子1α的用于预防或治疗外周动脉疾病的组合物
JP2004121266A (ja) コンビナトリアルポリペプチド抗原
KR19980064258A (ko) 항비만 단백질
WO2015042187A1 (en) Treatment of hepatitis d virus infections by redirection of t cells
JP2002538775A5 (https=)